<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 265 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page264.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=265">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 265 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 265</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=265"><img src="../thumb/265.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>228 / 2020-04                                                        Anti-Microbials - 18.1.1 / 18.1.2
   tremor, convuls., syncope, ileus, pain, malaise, CV eff.incl.card. ar-  Special precautions: Dehydrat., oligur., ren. fail., period.ren./  Peri-op.prophylax: 1,5 g IV 1-1.5 hrs.prior proced., supplem.with
   rest, photophob., thirst., taste pervers., psych. effs., vaginit., leuc-  hepat./bld.assessm.dur.prolong.ther., glandul.fev., lymphat.leukaem.,   750 mg IV/IM 8 hrly x  24-48 hrs. Card.& pulm.op: 1,5 g IV at anaesth.
   orrh., resp./pulm.effs.      pts.being treat. with allopurinol, excret.in breast milk.   induct. foll. by 1.5 g 12 hrly.x 24- 48 hrs.
   Warnings and special precautions: Poss.fatal hypersens. reacts.  Drug interactions: Effic.of oestrog.contain.OC’s decr., absorpt.of   Gonorrh: 1,5 g IM as sngl.dos./as two 750 mg inj.at diff.sites. Poss
   incl.shock, discont.in case of allerg.reacts., ser.hypersens.reacts.req.  other medic.poss.affect., absorpt. of concurr.digox.poss.incr.  given in combin.with 1 g oral probenecid.
   immed. emerg. meas., period.organ.syst.funct./ haematopoiet. funct.  Meningitis: Adults: 3 g IV 8 hrly.
   asessm.dur.prolong.ther., poss. bleed. manifestat., poss.neuromusc.   Infts.& childr.: 200-240 mg/kg/day IV in 3-4 div dos. poss. reduc.dos
   excitabil. /convuls.with high.than recomm.IV dos., electrol. deter-  aft.3 days to 100mg/kg/day when clinic.improvem.
   min.with low K+ reserv., Na content may incr.overall Na intake, imp. 18.1.2  Cephalosporins  Neonates: 100 mg/kg/day decr.to 50 mg/kg/day when indicat.
   ren.funct./ haemodialys., monit.coagulat.paramet.reg.with concom.   Contraindications:Safety in pregn.& lactat.& infts below 3
   meds.that affect.bld.coagulat./ thrombocyte funct., do not mix with   ZINNAT (MDR Listing)  mnths.not est.
   other meds.in syringe/infus., do not add to bld. products/album. hy-  ADCO CEFAZOLIN, (AI Crit.Care) AI Ltd [P/S]  Side effects: Hypersens.reacts., anaphylax. bronchsp., urticar., Stev.
   drolysates, consid.pseudomembran.colit.in presc. of diarrh., not to be   Cefazolin sodium equiv.to cefazolin.  Johns.& epiderm. necrolys., bone marrow depress., bld.dyscras.,
   used with sols. contain. only sod.bicarb., Ringer’s lact.sol.only com-  Indications: Suscept.organ.resp. tract, GUT, skin & skin struct.., bone   hepatit., cholestat.jaund., loc.reacts.aft.IMI, thrombophlebit. aft.
   pat. with TAZOCIN 4 EF formulat., cross.placenta, excret.in breast   & joint infects., septicaem., endocardit., peri-/intra-& post-operat.  IVI, CNS toxic.in pts with sev. ren. impair., GI disturbs, non-suscept.
   milk., treatm.of mix. infects.caus. by piperacillin suscept.organ./ ß-  prophylax.in abdom. hysterect.  organ. overgrowth
   lactamase produc. organ. suscept.to piperacillin/tazobactam should   (S4) POWD.FOR SOL FOR INJ, 36/20.1.1/0259, 0260  Special precautions: Poss.penicill./cephalospor. cross sens., imp.
   not req. addit.of anoth.antibiotic, monit.methotrex. ser.lev.if admin.  703372-002: 500 mg, 1 vial, R15,92  ren.funct., bleed.complicat.relat.to hypoprothrombinaem.& prolong.
   comcom.to avoid drug toxic.  703368-001: 1 g, 1 vial, R14,26  prothrombin time, Vit.K synthes.inhibit., poss.pseudomembr.colit.,
   Drug interactions: Probenec.produc.long half-life & lower ren.  Dosage: IV/IM admin/IV contin./intermitt.infus.  avoid concom.furosemide, monit.ren.funct.in eosinophil.pts., monit
   clear., poss.neuromusc.block. prolongat. of vecuronium, poss.prolong.   Adults: 250 mg-1,5 g 6-8-12 hrly. Norm.dos: 500 mg-1 g 6-12 hrly.   bone marrow in pts develop. decr.HB conc., ren.tubul.necros.in el-
   neuromusc. blockade of non-depolaris.musc.relax., piperacill. may   Sev.infect: up to 6 g/day. In life-threaten.infects.max.12 g/day   derly/pre-exist. ren.impairm./concom.nephrotox.drugs.
   reduc.methotrex.excret., inactivat. of aminoglycosid. when mix.tog.  has been used.  Drug interactions: Furosemide & aminoglycos. enhanc. nephrotox.
   See also MDR page 653.       Childr: 25-50 mg/kg bm/day in 3-4 div.dos. May be incr.to 100 mg/  potent., probenecid reduc.ren.clear.
   YOMAX, Actor Pharma [P/S]    kg bm/day in sev.infects.     ALKOXIME, (Ascendis) Alkem [P/S]
   Amoxicillin trihydrate equiv.to amoxicillin.  Peri-op.prophylax: 1 g IV ½-1 hr.prior to surg. For proced.2 hrs.or   Cefuroxime axetil.equiv.to cefuroxime.
   Indications: Mild to mod.sev.suscept.U&LRTI & GI infects., other   long.1 g IV/IM dur.surg.(modify dos. &dos.interv.accord.to proced.  Indications: Pharyngit., tonsillit., otit.media, sinusit., ac.& chron.
   infects.incl.Lyme dis., suscept. skin/soft tiss.infects.& UTI, com-  durat.) then 1 g IV/IM 6-8 hrly.postop x24 hrs. Post-op dos.has con-  bronchit., ac.uncomplic. cystit.& Lyme dis.in adults & childr.over
   binat.ther.in H.pylori infects.assoc.with duod.ulcerat., endocar-  tin. x5 days in cert.cases.  12 yrs.
   dit. prophylax.              Contraindications: Intrathecal admin.not an approv. route, safety   (S4) TABS, 44/20.1.1/0582, 0583
   (S4) CAPS, 41/20.1.2/0687, 0688  in pregn.& use in prems.& infts.und.1 mnth.not est.,  717799-001: 250 mg, 10, R116,07
   716122-001: 250 mg, 500, R265,22  Side effects: Hypersens.reacts.incl.anaphylax., bld.dyscras., bleed.  717801-001: 500 mg, 10, R215,96
   716123-001: 500 mg, 100, R109,67  disords.due.to hypoprothrombinaem. & or platelet dysfunct., incr. urea   Dosage: Admin.½.hr.aft.food.
   Dosage: Admin.tot.dly.dos.orally in div.dos.8 hrly.x48-72 hrs aft.  lev., nephrotoxic., hepatit.& cholestat.jaund., GI disturbs., CNS effs.  Sinusit., ac.& chron.bronchit: 250 mg 2xdly x7 days. (Range
   clinic.respons. Recomm.at least 10 days treatm.to be giv.for any   incl.convuls.at high dos., loc. reacts., superinfect.  5-10 days)
   beta-haemolyt. streptococc.infect. prevent. ac.rheum. fev. occurr.   Special precautions: Penicill.cross-sens., pseudomembr. colit.,   Ac.uncomplicat.cystit: 125 mg 2xdly x7 days. (Range 5-10 days)
   or glomerulonephrit.         imp. ren.funct., hist.of GI dis. partic.colit., crosses into breast milk  Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x20 days
                                          +
   Adults & childr.over 40 kg: Tot.dly.dos: 750 mg-3 g.admin.in div.  Drug interactions:.K  /loop diuret.& aminoglycosid. assoc with incr.
   dos. Max.recomm.dos. 6 g/day in div.dos.  incid.of ren.funct. impairm., probenecid decr.ren.excret.  Contraindications: Cephalosporin antibiot., penicill.& other ß-lac-
   Resp.infects: 500 mg 8 hrly.  ADCO-CEFTRIAXONE, (AI Crit.Care) AI Ltd [P/S]  tam hypersens., safety in pregn.& lactat.not est.
   Lyme dis: Isolat.erythema chronicum migrans: 4 g/day. Gen.mani-  Ceftriaxone.  Side effects: Bld.dyscras., hypersens.reacts.incl. anaphylax., head-
   fest: 6 g/day both for minim.of 12 days.  Indications: Bact.septicaem., meningit., intra-abdom./skin & skin   ache, dizzin., GI disturbs., trans hepat.enzyme lev.incr., jaund., erythe-
   Gonorrh: 3 g with 1 g probenecid.  struct./ bones &joint/ ren.& urin.tract/resp.tract & ENT infects., un-  ma multiforme /Stev.Johns & tox.epiderm.necrolys., vag.candidias.
   Eradicat.of H pylori infect.assoc.with duod. ulcerat.:   complic. gonorrh., peri-op.infect.prophylax.  Warnings and special precautions: GI dis. hist., ren.funct.im-
   750 mg-1 g in combinat.treatm.giv. 12 hrly.for 7 days.  (S4) INJ. 37/20.1.1/0042, 0043, 0044.  pairm., porphyr., investig.for poss. pseudomembr.colit.if suspect.,
   Childr.und.40 kg: 20-50 mg/kg/day in div.dos. Max recomm.dos:   703463-003: 500mg, 1 vial, R26,29  poss.penicill. & cephalospor.cross.sens., overgrowth of non-suscept.
   150 mg/kg/ day in div.dos.                                 organ.with prolong.use, Jarish-Herxheim. react. report.follow.Lyme
   Lyme dis: Isolat.erythema chronicum migrans: 25-50 mg/kg/day.   703463-004: 500 mg, 10 vials, R263,21  dis.treatm., may interact with some lab.tests.
                                703474-002: 1 g, 1 vial, R18,51
   Gen.manifest: 100 mg/kg/day both for minim.of 12 days.     Drug interactions: Probenecid incr.AUC, OC effic. poss.reduc.
   Dent./oral/URT proced: Prophylax.for undergo. dent.extract./  703474-003: 1 g, 10 vials, R185,17  ASPEN CEFPODOXIME, (Aspen Pharmacare: Pharma)
                                703466-006: 2 g, 1 vial, R58,88
   scal.or surg.involv.gingiv.tiss./ tonsillect./adenoidect./bronchos-  Pharmacare [P/S]
   copy/surg. proced. involv.resp.mucosa: Pts.not hav.gen. anaesthet:   703466-007: 2 g, 5 vials, R294,39  Cefpodoxime proxetil equiv.to cefpodoxime.
                                Dosage: Admin.IM/IV. IV infus.to be admin.over at least 30 mins.
   Adults: 2 g giv.1 hr.bef.proced. Childr. 50 mg/kg giv.1 hr.bef.proced.   Indications: Suscept.URTI/LRTI.
   Not to exceed.adult dos.     Durat.of ther.for min.of 48-72 hrs. aft. pt.afebr./eviden.bact.eradicat.  (S4) TABS, 42/20.1.1/0388, 0389
                                Adults incl.elderly & childr. over 12 yrs: 1-2 g once dly. may
   Contraindications: Penicill./cephalospor. hypersens., infect.mono-  718333-001: 100 mg, 10, R115,73
   nucleos., safety in pregn. not est.  be incr.to 4 g dly.   718334-001: 200 mg, 10, R154,90
   Side effects: Sev.hypersens.reacts.incl. anaphylax., superinfect.,   Neonates upto 14 days (not necess.to different. betw.prem. & term   (S4) SUSP, 42/20.1.1/0387 40 mg/5 ml
   pseudomembr.colit., hepatit., cholestat.jaund., GI disturbs.incl. sto-  infts): 20-50 mg/kg bm once dly. Dly.dos not to exceed 50 mg/kg. In-  719702-001, 50 ml, R88,12
   matit. /black hairy tong./enterocolit./ haemorrh. colit., mucocutan.  fts.& childr.(15 days – 12 yrs): 20-80 mg/kg bm once dly. Adult dos.  719702-002, 100 ml, R176,25
   candidias., superfic. tooth discolourat., skin rash, prurit., urticar., ser.   applic.to childr.with bm. over 50 kg.  Dosage: Admin.with meals.
   sickn.-like syndr., erythema multiforme, Stev. Johnson syndr., hyper-  Bact.meningit: Neonates/ infts.& childr: Init. 100 mg/kg (not to   Adults: 100-200 mg 12 hrly.
   sens.vasculit., exfoliat. dermatit., tox.epiderm.necrolys., CNS effs.  exceed 4 g) once dly.  Childr: Aver.dos: 8 mg/kg/day admin.in 2 dos.at 12 hrly interv.
   incl. headache/dizzin.& convuls., vaginit., tiredn., hot flush., interstit.  Adults: Recomm.4 g once dly.  Betw.10-15 kg: 5 ml 12 hrly. ≥15 kg: 10 ml 12 hrly.
   nephrit., crystallur., bld.dyscras., thrombocytos., prolong.bleed.&   Gonorrh: 125 mg IM as sngl.dose.  Contraindications: Prev.penicill./ cephalospor. hypersens., childr.&lt;1
   prothromb.time, death gen.assoc.with underly.dis./concom.meds.  Periop.-prophylax: Sngl.dos.of 1-2 g 30-90  mins. prior to surg.
   Special precautions: For endocardit.prophylax. consid.altern.  Contraindications: Hypersens., penicill.cross-sens., safety in   yr.as insuffic.clinic.data avail., safety in pregn.& lactat. not est. Susp
   antibiot.if pt.receiv.penicill.within prev.mnth./penicill.allerg., cepha-  pregn.& lactat.not est.  also: Phenylketonur.
   lospor./penicill. cross-sens., multipl.allerg.hist., period.organ funct.   Side effects: GI disturbs., stomatit., glossit., incr. liv enzym., pseu-  Side effects: Ser.hypersens.reacts.somet.fatal, GI disturbs.incl.di-
   assessm.with prolong.ther., hepat. dysfunct., concom.OC’s, excret.  domembr. colit., bld.dyscras., skin reacts.incl.exanthema, erythema   arrh., super-infect., skin reacts.incl. bullous erupt./eryth.multiforme/
   in breast milk, discont. immed.when anaphylact.reacts./ angioneu-  multiforme, Stev.-Johns.syndr./Lyell’s syndr./tox.epiderm.necrolys.,   Stev.-Johns. syndr., fev., ser.sickn.-like reacts., anaphylact. reacts. incl.
   rot. oed.occur & instit.appropr.ther., elderly, concom.anticoags., poss.  headache, dizz., oligur., genit.tract mycos., hypersens. reacts.incl.  bronchosp./anaphylact.shock, bld. dyscras., cholestat.jaund., hepatit.,
   Jarisch-Herxheim. react.in syphil.pts., adeq.fluid intake & urin.output   anaphylax., loc.reacts.at inj. site, fev., shiver, superinfect., precipit.  cholestas., CNS effs.incl.convuls.assoc.with high dos & esp. with
   at high dos., sod.-restrict.diet on high dos., lymphat.leukaem.as esp.  of ceftriaxone salts in gallbladd.caus.shadows detect. by gallbladd.  sev.ren. impairm., headache, dizzin., paraesthes., hear.loss, tinnit.,
   suscept.skin rash, mod.to sev.ren.impairm., discont.in superinfect.  sonogram mistak.for gallston.usual. follow. high.than recomm.dos.,   asthen., malaise, ren. dysfunct.
   Drug interactions: Incr.& prolong.bld.conc.with probenecid, effic.of   pancreatit., hyperbilirubinaem. neonates.  Warnings and special precautions: Penicill.& ß-lactam cross
   OC’s poss.reduc., incr.skin reacts. with allopurinol, tetracycl.& other   Special precautions: Cross.placenta barr.& excret. in breast milk,   sensitiv., discont.ther.in case of allerg. react., allergy hist., discont.
   bacteriostat. may interfer with bactericid.effs.  sev.ren./ hepat. dysfunct., do not add to sol contain.Ca, incompat.with   ther.if pseudomembran. colit.sympt.occur, ren.impairm., GI dis. hist.
                                                              esp.ulcerat.colit./reg.enterit./ antibiot. assoc. colit., elderly, diab.
                                vancomycin / fluconazole/aminoglycosid., neonates esp.prems.at risk
   ZOXIL, (Mylan) Xixia [P/S]   of develop.bilirubin encephalopathy.  with susp., lact.intol.
   Amoxycillin trihydrate equiv.to amoxycillin.               Drug interactions: Antacids & histam.H 2-recept. antagon.decr.ab-
   Indications: Suscept.non-penicillin.produc. organisms  ADCO-CEFUROXIME, (AI Crit.Care) AI Ltd [P/S]  sorpt., probenecid reduc.ren. excret., poss.antagon.with bacteriostat.
   (S4) CAPS, [P/S] 28/20.1.2/0124, 0125.  Cefuroxime as cefuroxime sodium.  antibact., poss. incr.bleed.risk with anticoags./warfar., ac. ren. tubul.
   808539-019: 250 mg, 15, R10,98  Indications: RT, ENT , bone & joint, skin & soft tiss infects, com-  necros.follow.nephrot.drugs eg aminoglycos.
   808547-003: 500 mg, 15, R22,04  mun.acquir.pneumonias, UTI, gonorrh., burn wound infects.caus.by
   (S4) SUSP, [P/S] 28/20.1.2/0126, 0127.  suscept. micro-organ., prophylax.of periop.infects.where infect.risk   AURO CEFALEXIN, Aurobindo [P/S]
   830739-009: 125 mg/5 ml, 100 ml, R13,57  incr., meningit.caus.by strep.pneum./H influenzae or N meningitidis.   Cephalexin monohydrate equiv.to cephalexin.
   830747-001: 250 mg/5 ml, 100 ml, R18,12  (S4) INJ, 36/20.1.1/0297, 0298, 0299.  Indications: Suscept.RTI, otit.media, dent./skin & soft tissue infects.
   Dosage: Adults: 250-500 mg 3xdly. Up to 6 g dly.in ser.infects.  704635-001: 750 mg, 1 vial, R25,79  (S4) TABS, 41/20.1.1/0388
   Childr.& infts: Admin. 3xdly.  704635-002: 750 mg, 10 vials, R258,22  714312-001: 500 mg, 20, R40,27
   2-10 yrs: 125 mg. 6 mnths-2 yrs: 125 mg. 0-6 mnths: 62,5 mg. Prem.  704637-001: 1,5 g, 1 x 20 ml vials, R55,73  Dosage: Adults: Dos.range 1-4 g dly.in equal.div. dos.usu-
   infts (ie.1-2,5 kg): 30-62,5 mg once dly.for 1st 1-2 wks.depend.on   704637-002: 1,5 g, 10 x 20 ml vials, R557,98  al.250 mg 6 hrly.
   size & maturity, thereaft.admin. 2-3xdly.  Dosage: Admin IM/IV or as IV infus.  Skin & soft tiss.infects./streptococc. pharyngit./ tonsillit./mild
   Contraindications: Penicill./ cephalospor. allergy, infect.mono-  Adults: Dos.range: 1,5-6 g/day. Infects.gen. respond to 750 mg 8   uncompl.UTI: 500 mg 12 hrly. Larg.dos.may be need.in more sev./
   nucleos.                     hrly & sev.infects 1,5 g IV 8 hrly. Freq.of IM or IV inj.may be incr.  infects. caus.by less suscept.organ. Parent.ther.should be consid.if
   Side effects: Allerg.reacts.incl.anaphylax./ Stevens-Johnson syn-  to 6 hrly if necess.  dos.larg.than 4 g reqd.
   dr., bld.dyscras., superinfects., GI disturbs., pseudomembran. colit.,   Infts over 3 mnths.& childr: 30-100 mg/kg/day in 3-4 div.dos. Ap-  Contraindications: Penicill.cross-sens., safety in pregn.& lactat.
   Jarisch-Herxheim.react.in syphil.pts.   prop.dos.for most infects: 60 mg/ kg/day.  not est., not suit.for childr.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page264.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page260.html">260</a>&nbsp;&nbsp;&nbsp;<a href="page261.html">261</a>&nbsp;&nbsp;&nbsp;<a href="page262.html">262</a>&nbsp;&nbsp;&nbsp;<a href="page263.html">263</a>&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>
             </td>
             <td width="35%"><a href="page266.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page266.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
